Robinson J, Biley F C, Dolk H
University of Ulster, School of Nursing, University of Ulster, Magee Campus, Londonderry, Northern Ireland, UK, BT48 7JL.
Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD006240. doi: 10.1002/14651858.CD006240.pub2.
Anxiety disorders are a common occurrence in today's society. There is interest from the community in the use of complementary therapies for anxiety disorders. This review examined the currently available evidence supporting the use of therapeutic touch in treating anxiety disorders.
To examine the efficacy and adverse effects of therapeutic touch for anxiety disorders.
We searched the Cochrane Collaboration Depression, Anxiety and Neurosis Controlled Trials Registers (CCDANCTR-Studies and CCDANCTR-References) (search date 13/01/06), the Controlled Trials website and Dissertation Abstracts International. Searches of reference lists of retrieved papers were also carried out and experts in the field were contacted.
Inclusion criteria included all published and unpublished randomised and quasi-randomised controlled trials comparing therapeutic touch with sham (mimic) TT, pharmacological therapy, psychological treatment, other treatment or no treatment /waiting list. The participants included adults with an anxiety disorder defined by the Diagnostic and Statistical Manual (DSM-IV),the International Classification of Diseases (ICD-10), validated diagnostic instruments, or other validated clinician or self-report instruments.
Two review authors independently applied inclusion criteria. Further information was sought from trialists where papers contained insufficient information to make a decision about eligibility.
No randomised or quasi-randomised controlled trials of therapeutic touch for anxiety disorders were identified.
AUTHORS' CONCLUSIONS: Given the high prevalence of anxiety disorders and the current paucity of evidence on therapeutic touch in this population, there is a need for well conducted randomised controlled trials to examine the effectiveness of therapeutic touch for anxiety disorders.
焦虑症在当今社会很常见。社会各界对使用辅助疗法治疗焦虑症很感兴趣。本综述研究了目前支持使用治疗性触摸治疗焦虑症的现有证据。
研究治疗性触摸治疗焦虑症的疗效和不良反应。
我们检索了Cochrane协作网抑郁症、焦虑症和神经症对照试验注册库(CCDANCTR-研究和CCDANCTR-参考文献)(检索日期为2006年1月13日)、对照试验网站和国际学位论文摘要数据库。还对检索到的论文的参考文献列表进行了检索,并联系了该领域的专家。
纳入标准包括所有已发表和未发表的随机和半随机对照试验,这些试验将治疗性触摸与假(模拟)治疗性触摸、药物治疗、心理治疗、其他治疗或不治疗/等待名单进行比较。参与者包括根据《诊断与统计手册》(DSM-IV)、《国际疾病分类》(ICD-10)、经过验证的诊断工具或其他经过验证的临床医生或自我报告工具定义的患有焦虑症的成年人。
两位综述作者独立应用纳入标准。如果论文包含的信息不足以决定是否符合资格,则向试验者寻求更多信息。
未发现关于治疗性触摸治疗焦虑症的随机或半随机对照试验。
鉴于焦虑症的高患病率以及目前该人群中关于治疗性触摸的证据不足,需要进行精心设计的随机对照试验来研究治疗性触摸治疗焦虑症的有效性。